<DOC>
<DOCNO>
EP-0004214
</DOCNO>
<TEXT>
<DATE>
19790919
</DATE>
<IPC-CLASSIFICATIONS>
A61P-31/00 A61P-31/12 A61K-38/43 A61P-31/16 A61K-38/00 A61K-38/46 C12N-9/24 
</IPC-CLASSIFICATIONS>
<TITLE>
pharmaceutical compositions containing a bacterial enzyme.
</TITLE>
<APPLICANT>
science union & ciefr<sep>science union et cie societe francaise de recherche medicale<sep>science union et cie societe francaise de recherche medicale14 rue du val d'orf-92150 suresnesfr  <sep>
</APPLICANT>
<INVENTOR>
forgeot marcelfr<sep>simon-lavoine nicolefr<sep>forgeot, marcel<sep>simon-lavoine, nicole<sep>forgeot, marcel26 rue bertholletf-75013 parisfr<sep>simon-lavoine, nicole2 rue du chateauf-92200 neuilly/seinefr<sep>
</INVENTOR>
<ABSTRACT>
in the new pharmaceutical compositions, the active principle is an enzyme obtained from microbial cultures.  the invention relates more specifically to pharmaceutical compositions intended for the treatment of viral diseases, characterised in that they contain as an active principle an n-acetylneuraminate glycohydrolase extracted from streptococcus pneumoniae cultures, in combination with a pharmaceutically acceptable, non-toxic, inert vehicle or excipient.  these compositions are intended for parenteral, permucosal, perlingual or rectal administration. 
</ABSTRACT>
</TEXT>
</DOC>
